New research: A mini-version of antibodies, called nanobodies, could eventually be used to treat neurocognitive disorders.
The approach could expedite the antibody-creation process and accelerate the discovery of therapeutic antibody candidates and vaccines.
Though newly approved for treatment of multiple myeloma, CAR T-cell therapy has, over the past few years, created new hope for patients with blood cancers. Researchers are now reviewing its effectiveness in treating solid tumors and brain tumors as well. Armed with the expertise and equipment to conduct numerous clinical trials involving CAR T-cells, the CU Cancer Center is one of the institutions on the leading edge of a revolution in cancer treatment.
The Princeton University Department of Chemistry’s Yang Lab publishes research on the first sorting technology that distinguishes nanoparticles through the mechanism of Watson-Crick digital recognition, thus enabling a new range of molecule-like building blocks.
A UCLA research team has developed a device that could be a major step forward: a smartwatch that assesses cortisol levels found in sweat — accurately, noninvasively and in real time. Described in a study published in Science Advances, the technology could offer wearers the ability to read and react to an essential biochemical indicator of stress.This device opens new possibilities for personal health monitoring.
The National Cancer Institute (NCI) has awarded a five-year grant to researchers at Winship Cancer Institute of Emory University who are developing nanoparticles to treat pancreatic cancer, one of the most deadly cancers.
Scientists from the University at Buffalo have developed a rapid new 3D bioprinting method that could represent a significant step towards fully-printed human organs.
A new portal at the University of South Florida Technology Transfer Office is improving accessibility for USF inventors and the general public, including companies interested in licensing inventions.